Skip to main content

ProMeritum Adds Arnaud Beernaert As Investor Relations Head

ProMeritum Investment Management, an emerging markets fixed income manager focussing on Eastern Europe, the Middle East and Africa (EEMEA), has appointed Arnaud Beernaert as its new Head of Investor Relations and Business Development.

Beernaert was previously Head of Business Development for Gladwyne Investments. Before that, Beernaert worked in senior capacities for other hedge funds, from large and established ones, such as BlueMountain Capital and Graham Capital, to start-ups, such as Areski Capital. Beernaert was previously also a Manager at McKinsey & Co and started his career as a corporate lawyer.

Pavel Mamai, Founding Partner of ProMeritum, says: “We are delighted to welcome Arnaud to the firm. He is an important hire for us and will help push the business forward in the next stage of our growth. Arnaud has significant experience raising capital for firms at all development stages, and complements this with a broader background in management consulting and law, which is rather unique”.

Beernaert adds: “I am delighted to be joining ProMeritum. It is a firm with a solid reputation, a clearly differentiated strategy and an institutional quality infrastructure which is typically not seen in organisations of that size. It speaks volumes about the ambitions of the team. I cannot wait to help the company grow and take it to the next level.”

Arnaud is a CFA Charterholder and also a keen runner, completing the Marathon des Sables, a weeklong 250 km running competition in the Moroccan Sahara. He is fluent in three languages: English, French and Dutch. 


© The Sortino Group Ltd

All Rights Reserved. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or scanning or otherwise, except under the terms of the Copyright, Designs and Patents Act 1988 or under the terms of a licence issued by the Copyright Licensing Agency or other Reprographic Rights Organisation, without the written permission of the publisher. For more information about reprints from AlphaWeek, click here.